Literature DB >> 21300103

Immunostimulatory and antigen delivery properties of liposomes made up of total polar lipids from non-pathogenic bacteria leads to efficient induction of both innate and adaptive immune responses.

Syed M Faisal1, Jenn-wei Chen, Sean P McDonough, Chao-Fu Chang, Ching-Hao Teng, Yung-Fu Chang.   

Abstract

Novel liposomes prepared from total polar lipids of non-pathogenic bacteria, viz. Leptospira biflexa serovar Potac (designated leptosomes) and Mycobacterium smegmatis (designated smegmosomes) were evaluated for their adjuvant effects with various antigen presenting cells (APCs), viz. murine macrophage cell line, J774A.1 and bone marrow derived dendritic cells (BMDCs). These liposomes induced strong membrane fusion as evident from resonance energy transfer (RET) assays and effectively transferred the fluorescent probe to the membrane of these APCs. Moreover, both vesicles caused significant activation of APCs as revealed by release of proinflammatory cytokines (IL-6, IL-12, TNF-α) and enhanced expression of co-stimulatory signals and maturation markers (CD80, CD86, MHCII), which was significantly higher for smegmosomes as compared to leptosomes. Additionally, activation of APCs by liposomes correlated with their ability to stimulate allospecific T cell proliferation and IFN-γ release. In contrast, conventional PC/chol liposomes failed to fuse and induced only a very low level of APC activation. Interestingly, the stimulatory activity of these lipid vesicles was restricted to APCs as they did not cause any significant activation or mitogenic effect on lymphocytes (B and T cells) in vitro. Overall, the activation of APCs by both leptosomes and smegmosomes correlated with activation of strong humoral and cell mediated immune responses in C57/BL6 mice to entrapped ovalbumin (OVA) and was significantly higher than those induced by conventional liposomes and alum, which failed to activate cytotoxic T lymphocytes (CTLs). Taken together these results demonstrate the adjuvant potential of these novel lipid vesicles that may simultaneously induce both innate and adaptive immune responses due to their immune stimulatory and antigen delivery properties.
Copyright © 2011 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21300103     DOI: 10.1016/j.vaccine.2011.01.110

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  6 in total

Review 1.  Liposomes as vaccine delivery systems: a review of the recent advances.

Authors:  Reto A Schwendener
Journal:  Ther Adv Vaccines       Date:  2014-11

2.  Ac2PIM-responsive miR-150 and miR-143 target receptor-interacting protein kinase 2 and transforming growth factor beta-activated kinase 1 to suppress NOD2-induced immunomodulators.

Authors:  Praveen Prakhar; Sahana Holla; Devram Sampat Ghorpade; Martine Gilleron; Germain Puzo; Vibha Udupa; Kithiganahalli Narayanaswamy Balaji
Journal:  J Biol Chem       Date:  2015-09-21       Impact factor: 5.157

3.  Protective effect of a lipid-based preparation from Mycobacterium smegmatis in a murine model of progressive pulmonary tuberculosis.

Authors:  Maria de los Angeles García; Reinier Borrero; Maria E Lanio; Yanely Tirado; Nadine Alvarez; Alina Puig; Alicia Aguilar; Liem Canet; Dulce Mata Espinoza; Jorge Barrios Payán; María Elena Sarmiento; Rogelio Hernández-Pando; Mohd-Nor Norazmi; Armando Acosta
Journal:  Biomed Res Int       Date:  2014-12-07       Impact factor: 3.411

4.  Inflammatory Signatures of Pathogenic and Non-Pathogenic Leptospira Infection in Susceptible C3H-HeJ Mice.

Authors:  Advait Shetty; Suman Kundu; Maria Gomes-Solecki
Journal:  Front Cell Infect Microbiol       Date:  2021-06-24       Impact factor: 5.293

5.  Evaluation of specific humoral immune response and cross reactivity against Mycobacterium tuberculosis antigens induced in mice immunized with liposomes composed of total lipids extracted from Mycobacterium smegmatis.

Authors:  María de los Angeles García; Reinier Borrero; Reynel Marrón; María E Lanio; Lien Canet; Oscar Otero; Ramlah Kadir; Siti Suraiya; Caridad Zayas; Yamilé López; Mohd Nor Norazmi; Maria E Sarmiento; Armando Acosta
Journal:  BMC Immunol       Date:  2013-02-25       Impact factor: 3.615

6.  Enhanced antitumor immune response in melanoma tumor model by anti-PD-1 small interference RNA encapsulated in nanoliposomes.

Authors:  Mehdi Barati; Farshad Mirzavi; Amin Reza Nikpoor; Mojtaba Sankian; Hasan Namdar Ahmadabad; Anvar Soleimani; Mohammad Mashreghi; Jalil Tavakol Afshar; Mojgan Mohammadi; Mahmoud Reza Jaafari
Journal:  Cancer Gene Ther       Date:  2021-08-02       Impact factor: 5.854

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.